Patent · US Active

Method for producing RNA

US10017826B2 · kind B2 · utility

23Cited by

15References

34Claims

0Family size

Assignee

CureVac AG · DE

Inventors

Florian Von Der Mülbe · Stuttgart, DE
Ladislaus Reidel · Rottenburg am Neckar, DE
Thomas Ketterer · Bingen, DE
Lilia Gontcharova · Reutlingen, DE
Susanne Bauer · Bodelshausen, DE
Steve Pascolo · Tübingen, DE
Jochen Probst · Wolfschlugen, DE
Andreas Schmid · Berkeley, US

Key dates

Filing date	Feb 15, 2016
Grant date	Jul 10, 2018
Priority date	—
Expiry date	Feb 15, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to a method for producing RNA. In particular, the present invention relates to a method for producing RNA, which is scalable and provides RNA at a high purity. The present invention provides a method for producing RNA under GMP and/or cGMP-compliant conditions. The invention further provides specific processes for use as a quality control in the manufacturing of a template DNA and/or in a method for producing RNA, in particular by in vitro transcription.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.